Swimming with the (pep)tides Stephen L. Gasior, Ph.D You have probably heard of the type 2 diabetes and weight loss drugs Ozempic, Mounjaro, Rybelsus, Wegovy, and Saxenda. These are a recent entry into the drug market and are expected to be billion dollar blockbusters. But, they also represent a whole new class of drugs with […]